Peritoneal metastasis (PM) after radical surgery is an important cause of treatment failure in colorectal cancer (CRC).
Intraoperative intraperitoneal perfusion chemotherapy may be an effective method for preventing postoperative PM in patients with CRC.
This study aimed to explore the safety and feasibility of intraoperatively preventive intraperitoneal perfusion chemotherapy using lobaplatin for CRC.
